<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="IE=edge" http-equiv="X-UA-Compatible"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../img/favicon.ico" rel="shortcut icon"/>
<title>Chronic Kidney Injury - MediWiki</title>
<link href="../../css/bootstrap.min.css" rel="stylesheet"/>
<link href="../../css/font-awesome.min.css" rel="stylesheet"/>
<link href="../../css/base.css" rel="stylesheet"/>
<link href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.5.0/styles/color-brewer.min.css" rel="stylesheet"/>
<script defer="" src="../../js/jquery-1.10.2.min.js"></script>
<script defer="" src="../../js/bootstrap.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/10.5.0/highlight.min.js"></script>
<script>hljs.initHighlightingOnLoad();</script>
</head>
<body>
<div class="navbar fixed-top navbar-expand-lg navbar-dark bg-primary">
<div class="container">
<a class="navbar-brand" href="../..">MediWiki</a>
<!-- Expander button -->
<button class="navbar-toggler" data-target="#navbar-collapse" data-toggle="collapse" type="button">
<span class="navbar-toggler-icon"></span>
</button>
<!-- Expanded navigation -->
<div class="navbar-collapse collapse" id="navbar-collapse">
<!-- Main navigation -->
<ul class="nav navbar-nav">
<li class="navitem">
<a class="nav-link" href="../../Basic%20Clinical%20Sciences.html">Basic Clinical Sciences</a>
</li>
<li class="navitem">
<a class="nav-link" href="../../Internal%20Medicine.html">Internal Medicine</a>
</li>
<li class="navitem">
<a class="nav-link" href="../../Surgery.html">Surgery</a>
</li>
<li class="navitem">
<a class="nav-link" href="../../Psychiatry.html">Psychiatry</a>
</li>
<li class="navitem">
<a class="nav-link" href="../../Critical%20Care.html">Critical Care</a>
</li>
</ul>
<ul class="nav navbar-nav ml-auto">
<li class="nav-item">
<a class="nav-link" data-target="#mkdocs_search_modal" data-toggle="modal" href="#">
<i class="fa fa-search"></i> Search
                            </a>
</li>
<li class="nav-item">
<a class="nav-link" href="Acute%20Kidney%20Injury.html" rel="prev">
<i class="fa fa-arrow-left"></i> Previous
                                </a>
</li>
<li class="nav-item">
<a class="nav-link" href="Dialysis%20in%20Renal%20Failure.html" rel="next">
                                    Next <i class="fa fa-arrow-right"></i>
</a>
</li>
</ul>
</div>
</div>
</div>
<div class="container">
<div class="row">
<div class="col-md-3"><div class="navbar-light navbar-expand-md bs-sidebar hidden-print affix" role="complementary">
<div class="navbar-header">
<button class="navbar-toggler collapsed" data-target="#toc-collapse" data-toggle="collapse" title="Table of Contents" type="button">
<span class="fa fa-angle-down"></span>
</button>
</div>
<div class="navbar-collapse collapse card bg-secondary" id="toc-collapse">
<ul class="nav flex-column">
<li class="nav-item" data-level="2"><a class="nav-link" href="#chronic-kidney-disease">Chronic Kidney Disease</a>
<ul class="nav flex-column">
</ul>
</li>
</ul>
</div>
</div></div>
<div class="col-md-9" role="main">
<h2 id="chronic-kidney-disease">Chronic Kidney Disease</h2>
<h3 id="a-general-characteristics">A. General Characteristics</h3>
<ol>
<li>
<p>Chronic kidney disease (CKD) is defined as either decreased kidney function (GFR &lt;60 mL/min) or kidney damage (structural or functional abnormalities) for at least 3 months, regardless of cause.</p>
</li>
<li>
<p>Causes</p>
</li>
</ol>
<p>a. Diabetes is the most common cause (30% of cases).</p>
<p>b. HTN is responsible for 25% of cases.</p>
<p>c. Chronic GN accounts for 15% of cases.</p>
<p>d. Interstitial nephritis, polycystic kidney disease, obstructive uropathy (BPH)</p>
<p>e. Any of the causes of AKI may lead to CKD if prolonged and/or if treatment is delayed.</p>
<ul>
<li>
<p>Pyelonephritis</p>
</li>
<li>
<p>Pathophysiology</p>
</li>
</ul>
<p>a. Plasma Cr varies inversely with GFR.</p>
<p>b. Cr clearance is the most common clinical measure of GFR (although remember
this is an indirect estimation and can lead to miscalculations).</p>
<p>c. An increase in plasma Cr indicates disease progression, whereas a decrease
suggests recovery of renal function (assuming muscle mass has not changed).
Most laboratories now also report an estimated GFR (eGFR) each time the
creatinine is ordered.</p>
<ol>
<li>More common in African-American than in Caucasian patients.</li>
</ol>
<p><img alt="" src="figs/Pasted%20image%2020220402135601.png"/>
<img alt="" src="figs/Pasted%20image%2020220402135608.png"/></p>
<h3 id="b-clinical-featuresany-of-the-following-may-be-present">B. Clinical Features—any of the following may be present:</h3>
<ol>
<li>Cardiovascular</li>
</ol>
<p>a. HTN</p>
<p>Secondary to salt and water retention—decreased GFR stimulates renin–
angiotensin system and aldosterone secretion to increase, which leads to an
increase in BP.
Renal failure is the most common cause of secondary HTN.</p>
<p>b. CHF—due to volume overload, HTN, and anemia.</p>
<p>c. Pericarditis (uremic).</p>
<ol>
<li>GI (usually due to uremia).</li>
</ol>
<p>a. Nausea, vomiting.</p>
<p>b. Loss of appetite (anorexia).</p>
<ol>
<li>Neurologic</li>
</ol>
<p>a. Symptoms include lethargy, somnolence, confusion, peripheral neuropathy, and
uremic seizures. Physical findings include weakness, asterixis, and
hyperreflexia. Patients may show “restless legs”—neuropathic pain in the legs
that is only relieved with movement.</p>
<p>b. Hypocalcemia (from decreased vitamin D conversion) can cause lethargy,
confusion, and tetany.</p>
<ol>
<li>Hematologic</li>
</ol>
<p>a. Normocytic normochromic anemia (secondary to deficiency of erythropoietin)
—may be severe.</p>
<p>b. Bleeding secondary to platelet dysfunction (due to uremia). Platelets do not
degranulate in uremic environment.</p>
<ol>
<li>Endocrine/metabolic</li>
</ol>
<p>a. Calcium–phosphorus disturbances.</p>
<ul>
<li>reduced renal clearance of phosphate → hyperphosphatemia  → Ca2+ precipitation → hypocalcaemia →  vascular calcifications that may result in necrotic skin lesions (calciphylaxis) → secondary hyperparathyroidism</li>
<li>reduced 1,25-(OH)2 vitD → hypocalcaemia → secondary hypoparathyoirdism</li>
<li>secondary hypoparathyoirdism → renal osteodystrophy → bone weakening and fractures</li>
<li>So, hypocalcemia and hyperphosphatemia are usually seen, but long-standing
secondary hyperparathyroidism and calcium-based phosphate binders may
sometimes cause hypercalcemia. This can be due to a parathyroid gland
secreting excess PTH without responsiveness to plasma calcium levels, known
as tertiary hyperparathyroidism.</li>
</ul>
<p>b. Sexual/reproductive symptoms due to hypothalamic–pituitary disturbances and
gonadal response to sex hormones: in men, decreased testosterone; in women,
amenorrhea, infertility, and hyperprolactinemia.</p>
<p>c. Pruritus (multifactorial etiology)—common and difficult to treat. Dialysis and
ultraviolet light.</p>
<ol>
<li>Fluid and electrolyte problems (see Chapter 8).</li>
</ol>
<p>a. Volume overload—watch for pulmonary edema.</p>
<p>b. Hyperkalemia—due to decreased urinary secretion.</p>
<p>c. Hypermagnesemia—occurs secondary to reduced urinary loss.</p>
<p>d. Hyperphosphatemia—see above.</p>
<p>e. Metabolic acidosis—due to loss of renal mass (and thus decreased production of
ammonia, which the kidneys use to buffer excreted acid) and the kidney’s
inability to excrete H+ itself.</p>
<ol>
<li>Immunologic—uremia inhibits cellular and humoral immunity.</li>
</ol>
<h3 id="c-diagnosis">C. Diagnosis</h3>
<ol>
<li>History<ul>
<li>Past UTI</li>
<li>known HTN, DM, FHx</li>
<li>Drug Hx</li>
<li>Fatigue, weakness, anorexia, vomiting, metallic tastes, pruritis, restless legs, bone pain, impotence/infertility</li>
</ul>
</li>
<li>Physical exam<ol>
<li>Pallor, yellow skin, brown nails, purpura, bruising, excoriation</li>
<li>HTN</li>
<li>cardiomegaly, pericardial rub, pleural effusion, pulmonary/peripheral oedema</li>
<li>proximal myopathy</li>
<li>Untreated: Arrhythmias, encephalopathy, seizures, coma</li>
</ol>
</li>
<li>Bedside tests<ul>
<li>Urinalysis—examine sediment (see AKI).<ul>
<li>Level of proteinuria is increasingly being reported alongside GFR as it is associated with more rapid progression of CKD.</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Laboratory</p>
<ul>
<li>Measure Cr clearance to estimate GFR.</li>
<li>FBC (anemia, thrombocytopenia).</li>
<li>EUC: Serum electrolytes (e.g., K+, Ca2+, PO4 3−, serum protein)</li>
<li>PTH</li>
<li>LFT (renal osteodystrophy elevates ALK)</li>
</ul>
</li>
<li>
<p>Imaging:</p>
</li>
<li>
<p>Renal ultrasound—evaluate size of kidneys/rule out obstruction.</p>
<ul>
<li>Small kidneys are suggestive of chronic renal insufficiency with little chance of
recovery.</li>
<li>Presence of normal-sized or large kidneys does not exclude CKD.</li>
</ul>
</li>
<li>Renal biopsy—in select cases to determine specific etiology.</li>
</ol>
<h3 id="d-treatment">D. Treatment</h3>
<ol>
<li>
<p>Early nephrologist referral</p>
</li>
<li>
<p>Diet and exercise</p>
</li>
</ol>
<p>a. Low protein—to 0.7 to 0.8 g/kg body weight per day: data suggests this may
slow progression of CKD.
b. Use a low-salt diet if HTN, CHF, or oliguria are present
c. Restrict potassium, phosphate, and magnesium intake.</p>
<ul>
<li>
<p>achieve healthy weight, stop smoking</p>
</li>
<li>
<p>ACE inhibitors—dilate efferent arteriole of glomerulus</p>
</li>
<li>
<p>If used early on, they reduce the risk of progression to ESRD because they slow the progression of proteinuria.</p>
</li>
<li>Use with great caution because they can cause hyperkalemia.</li>
<li>
<p>CVD control - consider statins (irrespective of baseline lipids), and aspirin</p>
</li>
<li>
<p>BP control</p>
</li>
</ul>
<p>a. Strict control decreases the rate of disease progression.
b. ACE inhibitors are the preferred agents. Multiple drugs, including diuretics, may
be required.</p>
<ul>
<li>
<p>aim for &lt;140/85; 130/80 if diabetic</p>
</li>
<li>
<p>Glycemic control (if the patient is diabetic) prevents worsening of proteinuria.</p>
</li>
<li>
<p>Correction of electrolyte abnormalities</p>
</li>
</ul>
<p>a. Correct hyperphosphatemia with calcium citrate (a phosphate binder).
b. Patients with chronic renal disease are generally treated with long-term oral
calcium and vitamin D in an effort to prevent secondary hyperparathyroidism
and uremic osteodystrophy.</p>
<p>Several clinical manifestations may result:</p>
<p>Osteitis fibrosa cystica</p>
<ul>
<li>aka hyperparathyroid bone disease</li>
</ul>
<p>Adynamic</p>
<ul>
<li>reduction in cellular activity (both osteoblasts and osteoclasts) in bone</li>
<li>may be due to over treatment with vitamin D</li>
</ul>
<p>Osteomalacia</p>
<ul>
<li>due to low vitamin D</li>
</ul>
<p>Osteosclerosis</p>
<p>Osteoporosis</p>
<p>c. Acidosis—treat the underlying cause (renal failure). Patients may require oral
bicarbonate replacement.</p>
<ol>
<li>
<p>Anemia—treat with erythropoietin, which kidneys normally secrete</p>
</li>
<li>
<p>Pulmonary edema—arrange for dialysis if the condition is unresponsive to diuresis; </p>
</li>
<li>
<p>try loop diuretics at high dose first (Furosemide 250mg-2g PO OD +/- metolazone 5-10mg PO OD mane) with restricted fluid/sodium intake</p>
</li>
<li>
<p>Restless legs - Clonazepam (0.5-2mg PO OD) or gabapentin trial</p>
</li>
<li>
<p>Pruritus—try capsaicin cream or cholestyramine and UV light</p>
</li>
<li>
<p>Dialysis (See indications in the Dialysis section.)</p>
</li>
<li>
<p>Transplantation is the only cure.</p>
</li>
<li>
<p>Ensure that you are dose adjusting based on kidney function</p>
<p><span class="arithmatex">\(DAF = \frac{1}{F(k_f - 1) + 1)}\)</span> where <span class="arithmatex">\(k_f = clearance_{creatinine}/120\)</span></p>
<ul>
<li>Drugs where F are large enough to be important include<ul>
<li>aminoglycosides - 0.9</li>
<li>lithium = 1.0</li>
<li>Digoxin = 0.75</li>
<li>Ethambutol = 0.7</li>
<li>Cephalosporins = 1.0</li>
<li>Sulfamethoxazole = 0.3-0.5</li>
<li>Procainamide = 0.6</li>
<li>Tetracycline = 0.4-0.6</li>
</ul>
</li>
</ul>
</li>
</ol></div>
</div>
</div>
<footer class="col-md-12">
<hr/>
<p>Copyright © 2021 Weber Liu</p>
</footer>
<script>
            var base_url = "../..",
                shortcuts = {"help": 191, "next": 78, "previous": 80, "search": 83};
        </script>
<script defer="" src="../../js/base.js"></script>
<script defer="" src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
<script defer="" src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
<script defer="" src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
<script defer="" src="../../search/main.js"></script>
<div aria-hidden="true" aria-labelledby="searchModalLabel" class="modal" id="mkdocs_search_modal" role="dialog" tabindex="-1">
<div class="modal-dialog modal-lg">
<div class="modal-content">
<div class="modal-header">
<h4 class="modal-title" id="searchModalLabel">Search</h4>
<button class="close" data-dismiss="modal" type="button"><span aria-hidden="true">×</span><span class="sr-only">Close</span></button>
</div>
<div class="modal-body">
<p>From here you can search these documents. Enter your search terms below.</p>
<form>
<div class="form-group">
<input class="form-control" id="mkdocs-search-query" placeholder="Search..." title="Type search term here" type="search"/>
</div>
</form>
<div data-no-results-text="No results found" id="mkdocs-search-results"></div>
</div>
<div class="modal-footer">
</div>
</div>
</div>
</div><div aria-hidden="true" aria-labelledby="keyboardModalLabel" class="modal" id="mkdocs_keyboard_modal" role="dialog" tabindex="-1">
<div class="modal-dialog">
<div class="modal-content">
<div class="modal-header">
<h4 class="modal-title" id="keyboardModalLabel">Keyboard Shortcuts</h4>
<button class="close" data-dismiss="modal" type="button"><span aria-hidden="true">×</span><span class="sr-only">Close</span></button>
</div>
<div class="modal-body">
<table class="table">
<thead>
<tr>
<th style="width: 20%;">Keys</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td class="help shortcut"><kbd>?</kbd></td>
<td>Open this help</td>
</tr>
<tr>
<td class="next shortcut"><kbd>n</kbd></td>
<td>Next page</td>
</tr>
<tr>
<td class="prev shortcut"><kbd>p</kbd></td>
<td>Previous page</td>
</tr>
<tr>
<td class="search shortcut"><kbd>s</kbd></td>
<td>Search</td>
</tr>
</tbody>
</table>
</div>
<div class="modal-footer">
</div>
</div>
</div>
</div>
</body>
</html>
